Embarc
Skip to content
Resources
Operating Companies
Capital Providers
Calendar
Sign in
Skip to content
Open menu
PBAX
Definitive Agreement
CERo Therapeutics
PHOENIX BIOTECH ACQUISITION CORP.
Sponsors:
Phoenix Biotech Sponsor
Registration
2021-09-13
Filed S1
IPO
2021-10-07
IPO, search begins
Definitive Agreement
2023-06-04
Agreement for merger
Completed
Not yet completed
Underwriter:
Cantor Fitzgerald
Leadership:
Chris Ehrlich
,
Daniel Geffken
,
Douglas Fisher
,
Brian G. Atwood
,
Kathleen LaPorte
,
Barbara Kosacz
,
Caroline Loewy
Raised
$155M
CIK
1870404
SPAC Ticker
PBAXU
Merger
CERo Therapeutics
Merged Ticker
Focus
Healthcare, Life Sciences
Sign in for detailed analysis →
External link:
SEC Filings
